F. Hoffmann-La Roche Ltd: Roche provides molecular testing solutions to identify and differentiate SARS-CoV-2 Omicron variants of concern

Roche and its subsidiary, Tib Molbiol, confirm that it has tests for research use that identify the SARS-CoV-2 subvariants of concern, Omicron: BA.1, BA.1.1, BA.2, BA.2.2, BA.3 and DeltaThe World

Related Keywords

Germany ,Japan ,United States ,Denmark ,Switzerland ,America ,Nathalie Meetz ,Karl Mahler ,Sabine Borngr ,Gerard Tobin ,Bruno Eschli ,Birgit Masjost ,Loren Kalm ,Thomas Schinecker ,Genentech ,Roche Group ,World Health Organization ,Drug Administration ,Population Health Management ,Roche Group Media Relations ,Roche Diagnostics ,Lightmix Modular ,Population Health ,Emergency Use Authorization ,Dow Jones Sustainability Indices ,Chugai Pharmaceutical ,Hoffmann ,Oche ,Rovides ,Olecular ,Testing ,Solutions ,Identify ,Differentiate ,Cars ,Micron ,Variants ,Concern ,